StockWatch
·
 Medicinal Chemicals and Botanical Products
Quarterly ResultJul 24, 2026, 06:46 AM

Philip Morris Q2 Net Rev +10.4% to $11.19B; EPS $1.80, down 7.7%

AI Summary

Philip Morris International reported Q2 2026 net revenues of $11.19 billion, a 10.4% increase year-over-year, and six-month net revenues of $21.34 billion, up 9.75%. However, Q2 diluted EPS decreased by 7.7% to $1.80, and six-month diluted EPS fell 8.4% to $3.36, primarily due to a $511 million impairment related to an RBH equity investment. The company also implemented a new organizational model with three reportable segments and completed the sale of certain consumer accessories businesses for $121 million.

Key Highlights

  • Q2 2026 net revenues increased 10.4% to $11.19 billion.
  • Q2 2026 diluted EPS decreased 7.7% to $1.80.
  • Six-month 2026 net revenues rose 9.75% to $21.34 billion.
  • Six-month 2026 diluted EPS decreased 8.4% to $3.36.
  • Operating income for six months increased 16.1% to $8.42 billion.
  • Recorded a $511 million impairment related to the RBH equity investment.
  • Net cash provided by operating activities for six months increased 66.3% to $5.09 billion.
  • Implemented new segment structure: International Smoke-Free, International Combustibles, and U.S.